SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-23-006119
Filing Date
2023-05-11
Accepted
2023-05-11 07:01:17
Documents
48
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q mnpr_10q.htm   iXBRL 10-Q 589251
2 CONSULTING AGREEMENT OF PRX CONSULTING mnpr_ex101.htm EX-10.1 37163
3 CERTIFICATION mnpr_ex311.htm EX-31.1 19131
4 CERTIFICATION mnpr_ex312.htm EX-31.2 17609
5 CERTIFICATION mnpr_ex321.htm EX-32.1 11564
11 mnpr_10qimg6.jpg GRAPHIC 16242
  Complete submission text file 0001654954-23-006119.txt   2961842

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA mnpr-20230331.xsd EX-101.SCH 33534
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnpr-20230331_lab.xml EX-101.LAB 193690
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mnpr-20230331_cal.xml EX-101.CAL 28430
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnpr-20230331_pre.xml EX-101.PRE 155975
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mnpr-20230331_def.xml EX-101.DEF 77228
42 EXTRACTED XBRL INSTANCE DOCUMENT mnpr_10q_htm.xml XML 360192
Mailing Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091
Business Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091 8473880349
Monopar Therapeutics (Filer) CIK: 0001645469 (see all company filings)

IRS No.: 320463781 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39070 | Film No.: 23908745
SIC: 2834 Pharmaceutical Preparations